Spots Global Cancer Trial Database for bronchioloalveolar lung carcinoma
Every month we try and update this database with for bronchioloalveolar lung carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | NCT00955305 | Large Cell Lung... Lung Adenocarci... Recurrent Non-S... Stage IV Non-Sm... Bronchioloalveo... | Bevacizumab Carboplatin Cixutumumab Paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | NCT00955305 | Large Cell Lung... Lung Adenocarci... Recurrent Non-S... Stage IV Non-Sm... Bronchioloalveo... | Bevacizumab Carboplatin Cixutumumab Paclitaxel | 18 Years - | National Cancer Institute (NCI) |